Skip to content

Feasibility, Acceptability, and Preliminary Effects of ISTDP for Personality Disorders in a Specialized Psychiatric Clinic

A Pilotstudy Investigating Feasability, Acceptability and Preliminary Effects of ISTDP (Intensive Short Term Dynamic Psychotherapy) for Patients with Personality Disorder in a Psychiatric Clinic Specialized on Depression, Anxiety and PTSD

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06591754
Enrollment
34
Registered
2024-09-19
Start date
2024-09-09
Completion date
2027-12-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality Disorder

Keywords

Personality disorder, ISTDP, Intensive Short-Term Dynamic Psychotherapy

Brief summary

The primary objective of this study is to evaluate the feasibility and acceptability of a 25-week combined group and individual therapy program using Intensive Short-Term Dynamic Psychotherapy (ISTDP) for patients diagnosed with personality disorders. The secondary objective is to investigate preliminary effects of the treatment in terms of reducing symtoms of depression, anxiety and emotion regulation difficulties.

Detailed description

The investigators vill investigate a 25-week treatment with ISTDP that consists of both weekly group- and individual therapy for patients diagnosed with personality disorder in a psychiatric clinic specialized on depression, anxiety and PTSD. The feasibility and acceptability and preliminary effects will be evaluated using a within-group design with repeated measures and qualitative interviews. Patients will be recruited from the clinic and the main inclusion criteria is that the patient have a personality disorder diagnosis.

Interventions

BEHAVIORALISTDP

Both the individual therapy and the group therapy is based on ISTDP (Intensive Short-Term Dynamic Psychotherapy), an affect-focused psychodynamic therapy method. The therapy focus on the relationship between feelings, anxiety and dysfunctional emotion regulation (i.e. defenses). The purpose is to increase the capacity of anxiety regulation in the patient and to help the patient identify the dysfunctional patterns developed to avoid internal stress and then gradually approach previously warded of feelings. The individual therapy consists of 25 weekly sessions. The group treatment consists of 18 weekly sessions and is structured in three phases. Phase one: Psychoeducation about anxiety and exercises in anxiety regulation. Phase two: patients takes turn to observe their own anxiety and defenses together with a therapist. Phase three: Every session two patients will work with a chosen problem and identify defenses, anxiety and feelings together with a therapist in front of the group.

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
Stockholm University
CollaboratorOTHER
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Personality disorder diagnosis (Clinical assessment using STIP-5) Speaks Swedish fluently

Exclusion criteria

Autism or intellectual disability Borderline, antisocial or narcissistic personality disorder diagnosis Need for interpreter Urgent social misery Psychotic disorder High suicidality

Design outcomes

Primary

MeasureTime frameDescription
Total number of sessions attended during the treatmentThroughout the treatment period, up to 25 weeksTotal number of sessions attended during the treatment
Patients experience of, and satisfaction with, the treatment assessed through qualitative interviewsImmediately after treatment completionPatients experience of, and satisfaction with, the treatment assessed through qualitative interviews
Depression symtomsBaseline, weekly throughout treatment, immediately after treatment completion and 6-month follow-upDepression symtoms will be measured with Patient Health Questionnaire (PHQ-9; (Kroenke et al., 2001)
Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)Immediately after treatment completion (25 weeks)Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)
Adverse events related to the treatmentFrom start of treatment up to. 6 month follow up.Adverse events related to the treatment
Number of individual sessions attended during the treatmentThroughout the treatment period, up to 25 weeksNumber of individual sessions attended during the treatment
Number of group sessions attended during the treatmentThroughout the treatment period, up to 25 weeksNumber of group sessions attended during the treatment
Number of dropoutsThroughout the treatment period, up to 25 weeksNumber of dropouts

Secondary

MeasureTime frameDescription
Fear of negative emotionsChange from baseline to post-treatment (25 weeks) and follow up 6 months after treatment.Fear of negative emotion scale (Gilbert et al., 2014) for assessing fear and avoidance of negative feelings.
Anxiety symtomsChange from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.Generalized Anxiety Disorder-7 (GAD-7; Spitzer et al., 2006) for assessing anxiety symtoms.
Emotions regulation difficultiesChange from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.Difficulties in Emotion Regulation Scale (DERS-16; Bjureberg et al., 2016) for assessing difficulties with emotions regulation.
Severity of personality disorderChange from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.The Standardized Assessment of Severity of Personality Disorders (SASPD; Olajide et al., 2018) for assessing degree of personality disorder.
Symtoms of Borderline Personality disorderChange from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.Borderline Symtom List (BLS-23; Bohus et al., 2008) for assessing symtoms of Borderline personality disorder.
Quality of lifeChange from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.Brunnsviken Brief Quality of life (Lindner et al., 2016) for assessing quality of life.
Working allianceWeekly throughout treatment , up to 25 weeksSession Alliance Inventory (SAI; Falkenström et al., 2015) for assessing the working alliance with the therapist
Emotional activation during therapyWeekly throughout treatment, up to 25 weeksEmotional Experience Self Report (Fisher et al., 2016) for assessing the degree of emotional activation during the session.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026